Distribution of Human Papillomavirus Types 16 and 18 Variants in Squamous Cell Carcinomas and Adenocarcinomas of the Cervix

Cancer Research

Volumn 63, Issue 21, 2003, Pages 7215-7220

  Burk, Robert D ^a   Terai, Masanori ^a   Gravitt, Patti E ^b,i   Brinton, Louise A ^b   Kurman, Robert J ^c   Barnes, Willard A ^d   Greenberg, Mitchell D ^e   Hadjimichael, Olympia C ^f   Fu, Leiping ^a   McGowan, Larry ^g   Mortel, Rodrigue ^h   Schwartz, Peter E ^f   Hildesheim, Allan ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e GRADUATE HOSPITAL   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; AFRICAN AMERICAN; ARTICLE; ASIAN AMERICAN; CELL LINEAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNIC GROUP; EUROPE; FEMALE; GENE CONTROL; GENE SEQUENCE; GENETIC VARIABILITY; HISTOPATHOLOGY; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MULTICENTER STUDY; OPEN READING FRAME; PAPILLOMA VIRUS; PHYLOGENY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION; UNITED STATES; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR VIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 10744221855     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. IARC. IARC monographs on the evaluation of carcinogenic risks to humans; Human Papillomaviruses, vol. 64, Lyon: WHO, 1995.
2. Pirog, E. C., Kleter, B., Olgac, S., Bobkiewicz, P., Lindeman, J., Quint, W. G. V., Richart, R. M., and Isacson, C. Prevalence of HPV DNA in different histologic subtypes of cervical adenocarcinoma. Am. J. Pathol., 157: 1055-1062, 2000.
3. Altekruse, S. F., Lacey, J. V., Brinton, L. A., Gravitt, P. E., Silverberg, S. G., Barnes, W. A., Greenberg, M. D., Hadjimichael, O. C., McGowan, L., Mortel, R., Schwartz, P. E., and Hildesheim, A. Comparison of HPV genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am. J. Obstet. Gynecol., 188: 657-63, 2003.
4. Lacey, J. V., Jr., Frisch, M., Brinton, L. A., Abbas, F. M., Barnes, W. A., Gravitt, P. E., Greenberg, M. D., Greene, S. M., Hadjimichael, O. C., McGowan, L., Mortel, R., Schwartz, P. E., Zaino, R. J., and Hildesheim, A. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control, 12: 153-161, 2001.
5. Xi, L. F., Koutsky, L. A., Galloway, D. A., Kuypers, J., Hughes, J. P., Wheeler, C. M., Holmes, K. K., and Kiviat, N. B. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J. Natl. Cancer Inst., 89: 796-802, 1997.
6. Villa. L. L., Sichero, L., Rahal. P., Caballero, O., Ferenczny, A., Rohan, T., and Franco, E. L. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol., 81: 2959-2968, 2000.
7. Hildesheim, A., Schiffman, M., Bromley, C., Wacholder, S., Herrero, R., Rodriguez, A., Bratti, M. C., Sherman, M. E., Scarpidis, U., Lin, Q. Q., Terai, M., Bromley, R. L., Buetow, K., Apple, R. J., and Burk, R. D. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl. Cancer Inst., 93: 315-318, 2001.
8. Matsumoto, K., Yoshikawa. H., Nakagawa, S., Tang, X., Yasugi, T., Kawana, K., Sekiya, S., Hirai, Y., Kukimoto, I., Kanda, T., and Taketani, Y. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett., 156: 159-165, 2000.
9. Berumen, J., Ordonez, R. M., Lazcano, E., Salmeron, J., Galvan, S. C., Estrada. R. A., Yunes, E., Garcia-Carranca, A., Gonzalez-Lira, G., and Madrigal-de la Campa, A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst., 93: 1325-1330, 2001.
10. Lizano, M., Berumen, J., Guido, M. C., Casas, L., and Garcia-Carranca, A. Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J. Natl. Cancer Inst., 89: 1227-1231, 1997.
11. Hecht, J. L., Kadish, A. S., Jiang, G., and Burk, R. D. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int. J. Cancer, 60: 369-376, 1995.
12. Lacey, J. V., Jr., Brinton, L. A., Abbas, F. M., Barnes, W. A., Gravitt, P. E., Greenberg, M. D., Greene, S. M., Hadjimichael, O. C., McGowan, L., Mortel, R., Schwartz, P. E., Silverberg, S. G., and Hildesheim, A. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol. Biomark. Prev., 8: 1079-1085, 1999.
13. Lacey, J. V., Jr., Brinton, L. A., Barnes, W. A., Gravitt, P. E., Greenberg, M. D., Hadjimichael, O. C., McGowan, L., Mortel, R., Schwartz, P. E., Kurman, R. J., and Hildesheim, A. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol. Oncol., 77: 149-154, 2000.
14. Gravitt, P. E., Brinton, L. A., Kornegay, J. R., Greenberg, M. D., Greene, S. M., Hadjimichael, O. C., McGowan, L., Mortel, R., Schwartz, P. E., Zaino, R., and Hildesheim, A. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by PCR. Cancer Epidemiol. Biomark. Prev., 10: 95-100, 2001.
15. Wheeler, C. M., Yamada, T., Hildesheim, A., and Jenison, S. A. Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J. Clin. Microbiol., 35: 11-19, 1997.
16. Ho, L., Chan, S. Y., Burk, R. D., Das, B. C., Fujinaga, K., Icenogle, J. P., Khan, T., Kiviat, N., Lancaster, W., Mavromara-Nazos, P., Labropoulou, V., Mitrani-Rosenbaum, S., Norrild, B., Pillai, M. R., Stoerker, J., Syrjaenen, K., Syrjaenen, S., Tay, S. K., Villa, L. L., Wheeler, C. M., Williamson, A. L., and Bernard, H. U. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol., 67: 6413-6423, 1993.
17. Ong, C. K., Chan, S. Y., Campo, M. S., Fujinaga, K., Mavromara, P., Pfister, H., Tay, S. K., Meulen, J. T., Villa, L. L., and Bernard, H. U. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J. Virol., 67: 6424-643, 1993.
18. Yamada, T., Wheeler, C. M., Halpern, A. L., Stewart, A. C. M., Hildesheim, A., and Jenison, S. A. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol., 69: 7743-7753, 1995.
19. Thomas, D. G., and Gart, J. J. Improved and extended exact and asymptotic methods for the combination of 2 × 2 tables, version 2.04. Comput. Biomed. Res., 25: 75-84, 2000.
20. Dixon, W. J., and Massey, F. J. Introduction to Statistical Analysis. 4 ed. New York: McGraw Hill, 1983.
21. Ursin, G., Peters, R. K., Henderson, B. E., d'Ablaing, G., III, Monroe, K. R., and Pike, M. C. Oral contraceptive use and adenocarcinoma of cervix. Lancet, 344: 1390-1379. 1994.
22. Madeleine, M. M., Daling, J. R., Schwartz, S. M., Shera, K., McKnight, B., Carter, J. J., Wipf, G. C., Critchlow, C. W., McDougall, J. K., Porter, P., and Galloway, D. A. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol. Biomark. Prev., 10: 171-177, 1999.
23. Fujiwara, H., Tortolero-Luna, G., Mitchell, M. F., Koulos, J. P., and Wright, T. C., Jr. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors. Cancer (Phila.), 79: 505-512, 1997.
24. Kanai, M., Shiozawa, T., Xin, L., Nikaido, T., and Fujii, S. Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer (Phila.), 82: 1709-1719, 1998.
25. Staebler, A., Sherman, M. E., Zaino, R. J., and Ronnett, B. M. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am. J. Surg. Pathol., 26: 998-1006, 2002.
26. Mittal, R., Pater, A., and Pater, M. M. Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions. J. Virol., 67: 5656-5659, 1993.
27. Chan. W. K., Klock, G., and Bernard, H. U. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J. Virol., 63: 3261-3269, 1989.
28. Stoppler, M. C., Ching, K., Stoppler, H., Clancy, K., Schlegel, R., and Icenogle, J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol., 70: 6987-6993, 1996.
29. Veress, G., Szarka, K., Dong, X.-P., Gergely, L., and Pfister, H. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16, J. Gen. Virol., 80: 1035-1043, 2000.
30. Tornesello, M. L., Buonaguro, F. M., Buonaguro, L., Salatiello, I., Beth-Giraldo, E., and Giraldo, G. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J. Gen. Virol., 81: 2969-2982, 2000.
31. Kammer, C., Warthorst, U., Torrez-Martinez, N., Wheeler, C. M., and Pfister, H. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J. Gen. Virol., 81: 1975-1981, 2000.
32. Choo, K. B., Wang, T. S., and Huang, C. J. Analysis of relative binding affinity of E7-pRB of human papillomavirus 16 clinical variants using the yeast two-hybrid system. J. Med. Virol., 61: 298-302, 2000.